| #60 |
Yair Sarig |
Oracle |
2 |
| #60 |
Dmitri Liakh |
Sap Ag |
2 |
| #60 |
Eric Voss |
Oracle |
2 |
| #60 |
Glen Van Datta |
— |
2 |
| #60 |
Mark S. Smyth |
Onyx Therapeutics |
2 |
| #60 |
Ming Yu |
Amgen |
2 |
| #60 |
Vinod Yegneswaran |
Sri International |
2 |
| #60 |
Michael R. Mish |
Gilead Sciences |
2 |
| #60 |
Cong Zhou |
Foxconn |
2 |
| #60 |
Hongmei Mo |
Abbott |
2 |
| #60 |
Daphne Preuss |
The University Of Chicago |
2 |
| #60 |
Seth Luisi |
Sony |
2 |
| #60 |
Chitra Baskaran |
Pharmacyclics |
2 |
| #60 |
Jeffrey H. Michaud |
Apple |
2 |
| #60 |
Chris S. Nelson |
Visa |
2 |
| #60 |
Hongtao Liu |
Gilead Sciences |
2 |
| #60 |
Joan C. Teng |
Oracle |
2 |
| #60 |
James Chieh-Tsung Chen |
Disney |
2 |
| #60 |
Eduardo R. Martins |
Sciclone Pharmaceuticals |
2 |
| #60 |
Hartmut Vogler |
Sap Ag |
2 |
| #60 |
Jonathan B. Buckheit |
Rudolph Technologies |
2 |
| #60 |
Steven Elliot Stupp |
Trigeminal Solutions |
2 |
| #60 |
Alex Goldstein |
Broadlight |
2 |
| #124 |
Stephan J. Jenne |
Codexis Mayflower Holdings |
1 |
| #124 |
Jack May |
Northrop Grumman |
1 |
| #124 |
Jeffrey Caldwell Fried |
Apple |
1 |
| #124 |
Rajendraprasad R. Pagaku |
Ironport Systems |
1 |
| #124 |
Thomas J. Kropewnicki |
Applied Materials |
1 |
| #124 |
Helen Shtargot |
Cisco |
1 |
| #124 |
Aleksey Skurikhin |
Oracle |
1 |
| #124 |
Shigenori Matsubara |
Konica Minolta Laboratory U.S.A. |
1 |
| #124 |
Jane Li |
IBM |
1 |
| #124 |
Erwin Hom |
Apple |
1 |
| #124 |
Weilan Ye |
Genentech |
1 |
| #124 |
Gary Hayato Ogasawara |
Lockheed Martin |
1 |
| #124 |
Pingu Ding |
Rigel Pharmaceuticals |
1 |
| #124 |
Jason Zoss |
Siebel Systems |
1 |
| #124 |
Diane Pennica |
Genentech |
1 |
| #124 |
Parmeet S. Chaddha |
IBM |
1 |
| #124 |
Aniket Kale |
Heliae Development |
1 |
| #124 |
Liusheng Zhu |
Amgen |
1 |
| #124 |
Dmitri Bronnikov |
Nutanix |
1 |
| #124 |
Zhiping Mu |
Argospect Technologies |
1 |
| #124 |
Georgios Konstantinos Paparrizos |
Qualcomm |
1 |
| #124 |
Qing Xu |
Global Blood Therapeutics |
1 |
| #124 |
Zhongxu Ren |
Nektar Therapeutics |
1 |
| #124 |
Venkat R. Thalladi |
Theravance Biopharma R&D Ip |
1 |
| #124 |
Jun Murakawa |
Sony |
1 |
| #124 |
Edward Doerffler |
Gilead Sciences |
1 |
| #124 |
Victor Octav Suba Miura |
— |
1 |